Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists

Ayako Ohnishi, Hisakazu Ohtani, Yasufumi Sawada

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aim: To evaluate quantitatively the influence of bioavailability and plasma unbound fraction (fu) on the extent of interaction between grapefruit juice (GFJ) and calcium antagonists. Methods: The extent of drug-GFJ interaction was evaluated from reported clinical interaction studies of 11 calcium antagonists. The relationship between extent of interaction and bioavailability or fu was analysed. Results: The following significant hyperbolic relationships were observed: [Extent] = 12.2/[bioavailability] + 1 and [Extent] = 0.718/[fu ] + 1. Conclusions: Bioavailability and fu are major determinant factors of calcium antagonist-GFJ interaction: a drug with smaller bioavailability or lower fu is likely to exhibit a more potent interaction, and vice versa.

Original languageEnglish
Pages (from-to)196-199
Number of pages4
JournalBritish Journal of Clinical Pharmacology
Volume62
Issue number2
DOIs
Publication statusPublished - 2006 Aug
Externally publishedYes

Fingerprint

Citrus paradisi
Calcium Channel Blockers
Biological Availability
Calcium
Drug Interactions
Pharmaceutical Preparations

Keywords

  • Calcium antagonist
  • Determinant factor
  • Grapefruit juice
  • Interaction

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists. / Ohnishi, Ayako; Ohtani, Hisakazu; Sawada, Yasufumi.

In: British Journal of Clinical Pharmacology, Vol. 62, No. 2, 08.2006, p. 196-199.

Research output: Contribution to journalArticle

@article{8a0fa16ec00341dd9bc66ba24376cd43,
title = "Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists",
abstract = "Aim: To evaluate quantitatively the influence of bioavailability and plasma unbound fraction (fu) on the extent of interaction between grapefruit juice (GFJ) and calcium antagonists. Methods: The extent of drug-GFJ interaction was evaluated from reported clinical interaction studies of 11 calcium antagonists. The relationship between extent of interaction and bioavailability or fu was analysed. Results: The following significant hyperbolic relationships were observed: [Extent] = 12.2/[bioavailability] + 1 and [Extent] = 0.718/[fu ] + 1. Conclusions: Bioavailability and fu are major determinant factors of calcium antagonist-GFJ interaction: a drug with smaller bioavailability or lower fu is likely to exhibit a more potent interaction, and vice versa.",
keywords = "Calcium antagonist, Determinant factor, Grapefruit juice, Interaction",
author = "Ayako Ohnishi and Hisakazu Ohtani and Yasufumi Sawada",
year = "2006",
month = "8",
doi = "10.1111/j.1365-2125.2006.02636.x",
language = "English",
volume = "62",
pages = "196--199",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists

AU - Ohnishi, Ayako

AU - Ohtani, Hisakazu

AU - Sawada, Yasufumi

PY - 2006/8

Y1 - 2006/8

N2 - Aim: To evaluate quantitatively the influence of bioavailability and plasma unbound fraction (fu) on the extent of interaction between grapefruit juice (GFJ) and calcium antagonists. Methods: The extent of drug-GFJ interaction was evaluated from reported clinical interaction studies of 11 calcium antagonists. The relationship between extent of interaction and bioavailability or fu was analysed. Results: The following significant hyperbolic relationships were observed: [Extent] = 12.2/[bioavailability] + 1 and [Extent] = 0.718/[fu ] + 1. Conclusions: Bioavailability and fu are major determinant factors of calcium antagonist-GFJ interaction: a drug with smaller bioavailability or lower fu is likely to exhibit a more potent interaction, and vice versa.

AB - Aim: To evaluate quantitatively the influence of bioavailability and plasma unbound fraction (fu) on the extent of interaction between grapefruit juice (GFJ) and calcium antagonists. Methods: The extent of drug-GFJ interaction was evaluated from reported clinical interaction studies of 11 calcium antagonists. The relationship between extent of interaction and bioavailability or fu was analysed. Results: The following significant hyperbolic relationships were observed: [Extent] = 12.2/[bioavailability] + 1 and [Extent] = 0.718/[fu ] + 1. Conclusions: Bioavailability and fu are major determinant factors of calcium antagonist-GFJ interaction: a drug with smaller bioavailability or lower fu is likely to exhibit a more potent interaction, and vice versa.

KW - Calcium antagonist

KW - Determinant factor

KW - Grapefruit juice

KW - Interaction

UR - http://www.scopus.com/inward/record.url?scp=33748269524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748269524&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.2006.02636.x

DO - 10.1111/j.1365-2125.2006.02636.x

M3 - Article

VL - 62

SP - 196

EP - 199

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 2

ER -